Purple Biotech Ltd (TLV:PPBT)
Israel
· Delayed Price · Currency is ILS · Price in ILA 4.100
+0.100 (2.50%)
May 13, 2025, 3:16 PM IDT
Purple Biotech Market Cap
Purple Biotech has a market cap or net worth of 21.71 million as of May 13, 2025. Its market cap has decreased by -63.84% in one year.
Market Cap
21.71M
Enterprise Value
-8.48M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
4.10
Market Cap Chart
Since July 14, 2013, Purple Biotech's market cap has increased from 17.87M to 21.71M, an increase of 21.47%. That is a compound annual growth rate of 1.66%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 68.75B |
| Danel (Adir Yeoshua) | 2.36B |
| Kamada | 1.45B |
| Bait Bakfar | 1.14B |
| Novolog (Pharm-Up 1966) | 794.87M |
| Ilex Medical | 689.63M |
| SofWave Medical | 646.14M |
| BrainsWay | 599.27M |